Litigation for clobazam

US Court Litigation for clobazam

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
8,603,514		0:19-cv-60757|S.D. Fla.	2019-03-22	2019-11-19	35:0271 Patent Infringement	District Court, S.D. Florida	Defendant
8,603,514		0:19-cv-60757|S.D. Fla.	2019-03-22	2019-11-18	35:0271 Patent Infringement	District Court, S.D. Florida	Defendant
8,603,514	Reckitt Benckiser Pharmaceuticals Inc. v. Par Pharmaceutical Inc.	1:13-cv-01461|D. Del.	2013-08-20	2014-05-27	35:271 Patent Infringement	District Court, D. Delaware	None
8,603,514		1:13-cv-01674|D. Del.	2013-10-08	2019-09-05	35:271 Patent Infringement	District Court, D. Delaware	None
8,603,514		1:13-cv-02003|D. Del.	2013-12-06	2014-05-09	28:1338 Patent Infringement	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for clobazam

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
8,603,514	Teva Pharmaceuticals USA Inc		2015-12-04	12-04-2015	MONOSOL RX LLC	Inter partes review		05-23-2016	Robert Yang
8,603,514	Dr. Reddy's Laboratories, Inc. et al.		2016-05-31	05-31-2016	MonoSol Rx, LLC	Inter partes review		12-05-2016	Robert Yang
8,603,514	Mylan Technologies, Inc. et al.		2016-11-04	11-04-2016	Yang et al	Inter partes review		05-12-2017
8,603,514	Par Pharmaceutical, Inc. et al.		2017-06-09	06-09-2017		Inter partes review		10-20-2017
8,603,514	Dr. Reddy’s Laboratories, Inc. et al.		2017-06-12	06-12-2017		Inter partes review		10-20-2017